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Abstract
Aims: Carbon monoxide (CO)-releasing molecules (CORMs) are candidates for animal and antimicrobial
therapeutics. We aimed to probe the antimicrobial potential of a novel manganese CORM.
Results: [Mn(CO)4S2CNMe(CH2CO2H)], CORM-401, inhibits growth of Escherichia coli and several antibiotic-
resistant clinical pathogens. CORM-401 releases CO that binds oxidases in vivo, but is an ineffective respiratory
inhibitor. Extensive CORM accumulation (assayed as intracellular manganese) accompanies antimicrobial activity.
CORM-401 stimulates respiration, polarizes the cytoplasmic membrane in an uncoupler-like manner, and elicits loss
of intracellular potassium and zinc. Transcriptomics and mathematical modeling of transcription factor activities
reveal a multifaceted response characterized by elevated expression of genes encoding potassium uptake, efflux
pumps, and envelope stress responses. Regulators implicated in stress responses (CpxR), respiration (Arc, Fnr),
methionine biosynthesis (MetJ), and iron homeostasis (Fur) are significantly disturbed.AlthoughCORM-401 reduces
bacterial growth in combinationwith cefotaxime and trimethoprim, fractional inhibition studies reveal no interaction.
Innovation: We present the most detailed microbiological analysis yet of a CORM that is not a ruthenium
carbonyl. We demonstrate CO-independent striking effects on the bacterial membrane and global transcriptomic
responses.
Conclusions: CORM-401, contrary to our expectations of a CO delivery vehicle, does not inhibit respiration. It
accumulates in the cytoplasm, acts like an uncoupler in disrupting cytoplasmic ion balance, and triggers multiple
effects, including osmotic stress and futile respiration.
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Introduction
There is an urgent need for new antimicrobial agents;carbon monoxide (CO)—a poisonous gas that avidly
binds to ferrous hemes in globins and oxidases inhibiting
respiration (29)—may, in principle, be a potent antimicrobial
molecule. However, CO also plays essential physiological
roles (35) as a gasotransmitter (50) [or small-molecule sig-
naling agent (18)]. CO is endogenously produced by heme
oxygenase that catalyzes the degradation of heme, liberating
CO, which then modulates key anti-inflammatory, anti-
apoptotic, and cytoprotective effects. However, the handling
and health risks associated with administering CO gas have
prompted the design and administration of CO-releasing
molecules (CORMs), predominantly metal carbonyl com-
pounds, allowing substantial advances in the biochemistry
and physiology of CO (8, 37). Diverse CORMs differ in
structure, kinetics, and in CO release mechanisms (70).
The first water-soluble CORM to be synthesized and used
biologically—[RuCl(glycinate)(CO)3], CORM-3—has been
widely exploited in models of vascular dysfunction, inflam-
mation, and ischemic injury (60). Subsequently, CORM-3
and other CORMs have been evaluated as antibacterial
agents that target critical oxidases or other iron sites, that is,
targets distinct from those of established antibiotics (9, 38).
CORM-3 remains the best studied CORM, although with a
complex solution chemistry (39), and over 150 articles have
appeared on its actions since 2003.
Rigorous bacterial chemostat experiments involving tran-
scriptomic datasets and mathematical modeling have re-
vealed unexpected aspects of CORM-3 biochemistry. First,
not only respiratory function but also diverse biological
processes are affected by CORM-3(38). Second, CORM-2
and CORM-3 elicit effects that cannot be mimicked by
CO gas, even at concentrations much higher than the ruthe-
nium (Ru) CORMs (73). Third, even CO-depleted control
molecules (so-called inactive CORM-3, iCORM) modulate
bacterial gene expression, despite the inability to detect sig-
nificant CO release from such molecules in the myoglobin
assay (38). Finally, although heme is the classical target of
CO in biological chemistry, heme-deficient bacteria are also
sensitive to CORM-3 and display complex patterns of gene
expression in response to this compound (74).
In view of the potential importance of CORMs as anti-
bacterial agents and the mounting evidence for involvement
Rebound Track
This work was rejected during standard peer review and
rescued by rebound peer review (Antioxid Redox Signal
16:293–296, 2012) with the following serving as open
reviewers: Miguel Aon, Giancarlo Biagini, James Imlay,
and Nigel Robinson. The comments by these reviewers
supporting the rescue are listed below:
Miguel Aon (miguel.aon@nih.gov): I am a qualified
reviewer (per Antioxid Redox Signal 16:293–296) and
move to rescue this article that was rejected during the
regular peer review process after reviewing all versions of
the article and detailed reviewer comments. The article
entitled The Broad-Spectrum Antimicrobial Potential of
[Mn(CO)4(S2CNMe(CH2CO2H))], a Water-Soluble CO-
Releasing Molecule (CORM-401): Intracellular Accu-
mulation, Transcriptomic and Statistical Analyses, and
Membrane Polarization represents a comprehensive in-
depth assessment of the antibiotic function of CORM-401,
a carbon monoxide-releasing manganese-based com-
pound. The most important scientific contribution of this
work is the detailed assessment of the mechanism of ac-
tion of CORM-401 to inhibit the growth of bacteria. The
emerging picture is of a pleiotropic nature, with multiple
targets that functionally converge on adverse bioenergetic
effects hindering bacterial growth. As a former Invited
Forum Editor and Author of Antioxidant & Redox Sig-
naling, I clearly understand and adhere to the journal’s
policy of scientific excellence. In this vein, I am confident
that the work by Wareham et al. fits those standards while
making a remarkable scientific contribution. The few
questions/concerns raised by the reviewers are not of en-
ough scientific substance to reject sound work based on a
substantial and comprehensive amount of evidence. The
key issue from this work is that perturbations of the proton
motive force elicited by CORM-401 are matched by en-
hanced respiration leading to membrane polarization,
which in turn drives the uptake of CORM-401 by bacteria,
poisoning them by its intracellular accumulation. This
seminal effect facilitates the intracellular action of
CORM-401 on multiple targets leading to growth arrest.
Therefore, in the interests of science, I take full respon-
sibility to rescue this work from rejection.
Giancarlo Biagini (giancarlo.biagini@lstmed.ac.uk):
I am a qualified reviewer (per Antioxid Redox Signal
16:293–296) and move to rescue this article that was re-
jected during the regular peer review process after re-
viewing all versions of the article and detailed reviewer
comments. The article investigates the mechanism of ac-
tion of a CO-releasing molecule and describes biochem-
ical, cellular bioenergetic, and transcriptional responses of
E. coli to CORM-401. The innovation of the article is that
these data are the first to describe the pharmacodynamics
of this second-generation CORM. The findings suggest a
pleiotropic mechanism of action, which includes disrup-
tion of respiratory chain components and of membrane
integrity in terms of ion transport/homeostasis. It is likely
that the disruption of these two biological functions is
linked. One of the referees questions the demonstration
that CORM-401 stimulates respiration. However, this is
clearly demonstrated in Figure 7. The experiments show
the use of the open O2 electrode, widely used and often in
Innovation
It is essential to investigate new carbon monoxide-
releasing molecules (CORMs) if the promised prospects
of site-specific and time-controlled release of CO are to be
exploited. We report the first detailed microbiological
characterization of the toxicity of the water-soluble CORM-
401, [Mn(CO)4(S2CNMe(CH2CO2H))], to Escherichia coli
strains and other pathogens. Our findings that CORM-401 is
an ineffective inhibitor of growth and respiration (despite
being accumulated to high levels), yet exerts profound ef-
fects on the bacterial membrane and global gene expression,
cast doubt on the mechanism of action of this CORM and
others. Such insights open the way for new compound de-
sign and novel, clinical combinatorial therapies.
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of the metal and co-ligand fragment of CORMs in their bi-
ological effects (38, 74), we have used a newer compound that
lacks Ru, a biologically foreign molecule. [Mn(CO)4S2CN-
Me(CH2CO2H)], CORM-401, is a CO-releasing manganese
complex providing up to 3.2 moles CO per mole of com-
pound (7), depending upon the concentration of the CO
acceptor myoglobin and the presence of oxidants (16). The
mechanism of CO loss is dissociative and reversible; re-
versible binding of CO results in a relatively stable solution
of the compound (7).
In this study, we present the most detailed microbiological
analysis to date of a non-Ru CORM and contrast its effects
with the potent actions of CORMs-2 and -3, whose actions
are probably explicable, in part, by the biological chemistry
of the accumulated Ru. Although less potent as an anti-
bacterial agent, CORM-401 is extensively accumulated by
bacteria, increases oxygen consumption and membrane po-
larization in an uncoupler-like manner, and triggers myriad
effects, including osmotic and envelope stresses.
Results
CORM-401 releases CO under bacterial
growth conditions
Medium or buffer composition and the presence of oxi-
dants, reductants, and a CO acceptor (such as a heme protein)
are important determinants of the rates and extent of CO loss
from CORMs (16, 39). We therefore characterized CO re-
lease from CORM-401 in vitro under our conditions using
ferrous myoglobin assays in which maximum sensitivity was
achieved by monitoring the Soret bands in CO difference
spectra (39) (Fig. 1A). In defined (Evans) growth medium, at
physiological temperature (37C) and pH (7.4), 2.5mol
equivalent of CO was released to myoglobin with a half-time
of 4.5min. In 0.1 M KPi buffer at 37C, the half-time was
5min and the yield of CO was 2.4mol/mol; at 20C, the rate
was slower (Supplementary Fig. S1; Supplementary Data
are available online at www.liebertpub.com/ars). Fayad-
Kobeissi et al. (16) reported that the yield of CO increased as
the myoglobin:CORM-401 ratio increased, with 2.6mol ob-
served at a ratio of 5:1. This is in close agreement with our
values (Fig. 1B and Supplementary Fig. S1).
Although sodium dithionite facilitates CO release from
CORM-3, CORM-401 is able to release CO spontaneously in
the absence of dithionite with oxyhemoglobin as a CO ac-
ceptor (39). The CO release kinetics in Figure 1 demonstrate
the rapid release from CORM-401 of CO in growth medium;
whether CO is released before, during, or after CORM uptake
(see Fig. 3), the gas will be available in the following bac-
terial experiments.
CORM-401 toxicity is dependent on the carbon
source for growth
The effect on bacterial growth was determined by adding
CORM-401 to mid-exponential phase cultures in replicate
experiments (representative cultures are shown in Fig. 2A,
B). CORM-401 slightly perturbed growth of cells on glucose
at 67 lM and significantly slowed growth only at 500lM
(Fig. 2A). When CO is liberated from CORM-401, an Mn(II)
salt and a dithiocarbamate (DTC) ligand remain. In minus-
CO control experiments, a combination of Mn(II) sulfate and
preference to the closed system, as one that has the ability
to set the dissolved O2 tension of the chamber, which
clearly demonstrates stimulation of O2 consumption fol-
lowing the introduction of CORM-401. The positive
control experiment using KCN clearly indicates that the
system is working normally. In vivo data are required to
establish the development potential of molecules, but in
this case, this investigation is first attempting to determine
the molecular mechanisms underpinning the activity of
this class of compounds. It is therefore not normal practice
to conflate the two issues. Therefore, in the interests of
science, I take full responsibility to rescue this work from
rejection.
James Imlay (jimlay@illinois.edu): I am a qualified
reviewer (per Antioxid Redox Signal 16:293–296) and
move to rescue this article that was rejected during the
regular peer review process after reviewing all versions of
the article and detailed reviewer comments. I have closely
read the article and the reviewers’ comments. My overall
reaction is that the article is sound, and I advise that a
decision be made to accept the article. I was surprised by
the outcome. I would have predicted that toxicity was
mediated by the usual action of CO. The loss of viability in
Figure 2 was enough to alert me that I was wrong. This is
nice work. A reviewer requested in vivo analysis, but
because these compounds impact host cells, a study of
CORM-401 impact in host animals would be large and
complex. Another wrote: authors should determine O2
consumption rate. This method is not new. Standard
measurements of consumption (Fig. 7B) are problematic
when rates are low. However, in Figure 7C and 7D, the
reader can immediately see that CORM-401 and carbo-
nylcyanide m-chlorophenylhydrazone cause an increase in
oxygen consumption, as evidenced by the lower steady-
state oxygen level. The same reviewer wrote: oxygen
consumption or even OCR could increase due to several
processes other than respiration. I disagree with the re-
viewer’s suggestion that nonrespiratory processes could
accelerate oxygen consumption. E. coli lacks non-
respiratory enzymes that employ molecular oxygen as a
substrate as this facultative bacterium must manage bio-
synthesis without oxygenases. Indeed, if one knocks out
respiratory oxidases, oxygen consumption essentially cea-
ses. Therefore, in the interests of science, I take full re-
sponsibility to rescue this work from rejection.
Nigel Robinson (nigel.robinson@durham.ac.uk): I am
a qualified reviewer (per Antioxid Redox Signal 16:293–
296) and move to rescue this article that was rejected
during the regular peer review process after reviewing all
versions of the article and detailed reviewer comments.
Carbon monoxide-releasing molecules (CORMs) might
be a new class of antimicrobials, with the looming threat
of antimicrobial resistance making work to explore such
options pertinent. In this study, multiple approaches
have explored facets of bacterial physiology (respira-
tion, transport, and membrane integrity) and molecular
cell biology (including extensive expression profiling)
to carefully tease apart the mechanism(s) of bacterial
growth inhibition by CORM-401. The resulting obser-
vations do not mirror the effects of related ruthenium-
containing CORMs, nor does exposure of cells to CO
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sarcosine DTC was added to final concentrations of 500lM
with no deleterious effect on growth (Fig. 2A, inset).
We hypothesized that succinate-grown cells would be per-
turbed by CORM-401 to a greater extent than on glucose due
to physiological reliance on heme terminal oxidases that are
inhibited by CO. Indeed, growth on succinate was inhibited to
a greater extent by CORM-401 (Fig. 2B); unlike glucose-
grown cells, cells failed to grow on succinate with 500lM
CORM-401 (Fig. 2B). Although inhibition of oxidase function
may contribute to this distinction, this article reveals a multi-
tude of effects on unrelated cellular functions. The control
compounds again showed no deleterious effect on growth
(Fig. 2B, inset). To dissect the effect of COgas and the CORM,
we tested the addition of a CO-saturated solution on growth of
cell cultures. Due to limitations of CO solubility and the un-
desirability of adding large volumes of gas solutions to cul-
tures, a final concentration of 100lM was used; no inhibition
of growth was observed (data not shown), as shown before
(69). Thus, the observed effects of CORM-401 on growth are,
in part, attributed to the metal co-ligand fragment of the
compound and not the CO alone as previously supposed.
Bactericidal activity of the compound was assessed by
viable counts. Note, however, there is no useful correlation
between biomass as assessed by optical density (light scat-
tering) measurements (Fig. 2A, B) and viable cell numbers as
assessed by colony counting after dilutions (Fig. 2C, D).
Light scattering certainly does not give information on the
number of cells (17, 32). Although glucose-grown cultures
increased in total biomass at <100lM CORM-401, viability
on agar decreased at 500lM after 2 h (Fig. 2C). In contrast,
cells grown on succinate (Fig. 2D) retained their viability on
agar, even at 500lM CORM-401, despite a lack of increase
in biomass (Fig. 2B). The apparent discrepancy in these two
media might result, for example, from the clumping of cells
in glucose (leading to an artifactually low cell count) or the
ability of succinate-grown cells to retain viability after re-
moval from the CORM, although being inhibited within the
CORM-supplemented culture.
CORM-401 accumulates to millimolar concentrations
in the bacterial cytoplasm and binds DNA
We hypothesized that the loss of viability of glucose-
grown cells (Fig. 2C) might be due to substrate-dependent
differences in CORM uptake. CORMs-2 and -3 are accu-
mulated by bacteria, as inferred from intracellular Ru
concentrations (9, 27, 38). Therefore, intracellular accumu-
lation of CORM-401 was measured using inductively cou-
pled plasma mass spectroscopy (ICP-MS) (38). However, the
metal in CORM-401 is Mn, itself a component of all cells,
and so we sought elevated accumulation of this metal relative
FIG. 1. CO release from CORM-401 in bacterial
growth medium. Assays were performed in Evans min-
imal medium (with glucose as sole carbon source) in the
presence of excess dithionite at 37C. (A) CO difference
spectra showing the conversion of myoglobin (15lM) to the
carbonmonoxy-ferrous species in the presence of 3 lM
CORM-401. (B) Time course of CO release from CORM-
401 in medium at 37C. Under these conditions, CORM-401
releases 2.5 mole equivalent of CO with a t1/2 of 4.5min.
Data are means of three biological repeats – SEMs. CORM,
carbon monoxide-releasing molecule.
alone mimic the effects of CORM-401: these data thus
point to features of the compound other than solely the
liberated CO exerting inhibitory effects, with manga-
nese, as opposed to ruthenium, appearing to be one
crucial distinction. The work is a tour de force; in short,
the action of CORM-401 is multifaceted and includes
not only CO binding to respiratory oxidases but also
manganese hyperaccumulation with effects on the ho-
meostasis of other metals (such as zinc), ionic imbalance
and loss of membrane integrity, and defined regulons.
The extent of functional studies was questioned, yet the
work is rich in a diversity of types of functional studies;
these assays have demanded a high degree of technical
skill in using a wide range of methodologies. Evidence
that the compound stimulates respiration was ques-
tioned. However, bacterial respiration rates have been
determined from measurements of oxygen concentra-
tions and oxygen diffusion rates. Editorial comments
note the lack of in vivo studies: it may be felt that ulti-
mately the compound should be used in animal models
of infection, but the modest effectiveness of this CORM
as an antimicrobial agent suggests that animal studies
are not justified (or perhaps ethical). Therefore, in the
interests of science, I take full responsibility to rescue
this work from rejection.
4 WAREHAM ET AL.
to no-CORM controls. Cells growing on glucose or succinate
in the presence of CORM-401 at two concentrations were
assayed over time and concentrations of manganese were
determined in cell pellets, using literature values for cell size
and volume to estimate cellular concentrations.
When cells were grown on glucose with 67 lM CORM-
401, manganese accumulated biphasically (Fig. 3A, closed
circles), rapidly within 2.5min, thenmore slowly over 80min
to reach an intracellular concentration of *3.5mM manga-
nese. In contrast, uptake by succinate-grown cells was
monophasic, reaching*1.5mM after 80min (Fig. 3A, open
circles). Thus, in glucose media, bacteria accumulate more
CORM-401 (Fig. 3A). Since 500lMCORM-401 was needed
to significantly slow growth, we also tested this concentration
and assayed cell pellets after 80min of growth; in cells grown
on glucose or succinate, the values found in cell pellets were
16.5 – 0.69mM and 10.9 – 0.55mM, respectively. The data
sets are statistically different ( p < 0.05). Thus, irrespective of
the CORM concentration in media, bacteria accumulate more
CORM-401 in glucose media and suffer reduced viability
(Fig. 2C). Note, however, most of the accumulated manga-
nese will be bound and buffered such that the exchangeable
concentration within living cells will be much lower than the
maximum of 3.5mM that we recorded. Therefore, an ap-
parent concentration of, say, 3.5mM manganese is better
expressed as 0.7 · 107 atoms/cell (see the Materials and
Methods section).
To determine the fate of accumulated manganese, cultures
exposed to 67lM CORM-401 were harvested and fraction-
ated to give soluble, membrane, and genomic DNA fractions,
which were retained and quantitatively analyzed for man-
ganese by ICP-MS. As shown in Figure 3B, manganese was
found predominantly not only in the cytoplasm but also in
DNA. CORM-401 itself is unlikely to coordinate DNA, but
pyridine reacts to give Mn(CO)3(py)(DTC), as observed by
IR spectroscopy (7), suggesting that an N base in DNA could
behave similarly. A protein histidine residue is a candidate
for binding of CORM-3 (59).
It was important to define the active species of CORM-
401; this might be CO released from the compound, the
FIG. 2. CORM-401 inhibits growth of Escherichia coli and is bactericidal to glucose-grown cells. Cells were grown
to the exponential phase before addition of CORMs at time = 0. (A) Growth supplemented with glucose in the absence of
CORM-401 (closed circles) and after addition of 10 lM (open circles), 67 lM (open triangles), and 500lM (squares)
CORM-401. (B) Growth supplemented with succinate, symbols as above. Insets in (A) and (B) Growth with 500 lM DTC/
MnSO4 on glucose and succinate showed no deleterious effect on growth of cells. (C) Viable counts at hourly intervals of
cells growing on glucose. (D) Viable counts of cells growing on succinate. Following the addition of CORM-401 to E. coli
MG1655 at OD600 0.6, cells were incubated for 90min before sampling; * indicates p£ 0.008. Data are representative of
three biological repeats.
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residual Mn(II) salt, or the DTC ligand. In the absence of
CORM, the Mn levels of succinate-grown cells were higher
than for glucose-grown cells (Fig. 3C) (note the different
ordinate scales in Fig. 3A, C, D). However, metal levels were
not influenced by CO in solution, even at 500lM, after
80min of incubation. Adding MnSO4 (500 lM) increased the
intracellular Mn levels, as expected, but a combination of
MnSO4 and DTC was without further effect. We conclude
that the modest increases observed in the control experiments
in Figure 3C and D demonstrate that CORM-401, but not the
control species (Mn, CO, DTC), significantly elevates in-
tracellular Mn pools.
Exposure to CORM-401 leads to transient changes
in transcription of multiple gene groups
The accumulation of CORM-401 to strikingly high levels
and correlation with bacterial killing (Figs. 2, 3) prompted
further analysis of global responses to this CORM. We
therefore conducted transcriptomic analyses on CORM 401-
treated cells in glucose medium. The concentration of CORM
selected (67lM) led to minor growth perturbation. Lethal
concentrations of CORM were avoided: we sought tran-
scriptomic responses to stress responses, rather than cell
death. CORM-401 altered expression of numerous genes in
distinct classes (Fig. 4). Following standard practice, we re-
tained, for our initial analysis, genes exhibiting a fold change
‡2-fold up or ‡2-fold down (the latter representing a change
of ‡0.5 of the control transcript level). We then performed in-
depth analyses of the transcriptomic response using the sta-
tistical modeling approach of TFInfer.
The response was transient both aerobically and anaero-
bically. Aerobically, 23% of the genome was significantly
up- or downregulated within 40min (Fig. 4A). Anaerobi-
cally, although the magnitude of gene changes across many
of the categories was smaller, and the response slightly de-
layed, the pattern in the response was again transient; at
40min, gene changes were highest with 18% of the entire
genome changing (Fig. 4B).
Aerobically, the most marked changes were in genes in-
volved in motility and energy, carbohydrate, and nucleotide
metabolism (Fig. 4A). The most altered category was motility;
after 40min of exposure to CORM-401 in aerobic conditions,
35% of genes in this category were downregulated, consistent
with the compromised motility of cells treated with a solution
of CO (38). However, we found that motility (swarming) of
FIG. 3. Manganese levels in cells treated with CORM-401 or control compounds. (A) Intracellular Mn levels in
E. coli grown on 20mM glucose (closed circles) or 20mM succinate (open circles), then treated with CORM-401 (final
concentration 67 lM); n = 3, –SEM. (B) Localization of Mn following addition of 67 lM CORM-401 (gray bars) to E. coli
MG1655 subcellular fractions. Black bars show Mn amounts in each fraction with no additional CORM-401. (C) Mn levels
in cells incubated for 80min in the presence (black bars) or absence (gray bars) of a saturated CO solution (*500lM, final
concentration). (D) Mn levels in cells before additions (black bars) or after adding 500 lM MnSO4 –67mM DTC.
n = 3,– SEM. Note the different scales in (A–D).
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cells was not diminished by CORM-401 (see ‘‘CORM-401
causes induction of the Cpx and Bae regulons, altering the
expression of Spy and CpxP proteins but without measurable
membrane damage to cells’’ section). Energy metabolism
genes were transiently affected by the addition of CORM-401
under aerobic conditions; genes were downregulated pro-
gressively over time and reached a minimum at 20min where
24% of energy metabolism-related genes were downregulated
(Fig. 4A). Anaerobically, the gene categories most affected
were those involved in energy metabolism, carbohydrate me-
tabolism, phosphotransferase system genes, and motility
(Fig. 4B). Genes involved in energy metabolism were more
highly downregulated anaerobically than aerobically (Fig. 4B
and Fig. 6). Signal transduction genes and genetic information
processing genes were highly upregulated: 17% of signal
transduction genes were upregulated after 20min.
Genes are described subsequently according to their func-
tional characteristics. However, Supplementary Table S1
presents a list of the thirty most highly upregulated genes,
both aerobically and anaerobically.
Modeling of transcriptomic data. To analyze the under-
lying transcription factors (TFs) responsible for the tran-
scriptome data, we used TFInfer (2, 57, 69), a Bayesian
statistical method that integrates gene expression data with
regulon information (culled from Regulon DB or EcoCyc) to
identify TF activity profiles that aid in understanding of the
raw transcriptional changes. We ran TFInfer separately on the
CORM-401 (this work) and CO gas data sets (69) to identify
differences in the magnitude and kinetics of the response to the
two stimuli. Figure 5 summarizes the differences between two
sets of TFInfer data using coherence plots [introduced in (69)];
FIG. 4. Functional categories of genes affected by CORM-401 under aerobic and anaerobic conditions. Genes are
grouped according to functional categories. The bars show the percentage of genes in each group that exhibit significantly
altered gene expression (i.e., where fold changes are ‡2 and £0.5) under (A) aerobic conditions and (B) anaerobic
conditions. Gene changes are shown as genes upregulated (right, black bars) and downregulated (left, gray bars) in each
group.
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FIG. 5. TFInfer correlation profiles (coherence plots) showing TFs involved in the response to CORM-401 versus
CO gas in E. coli cells. The x-coordinate of each point represents the profile difference between CORM-401 and CO
treatments, computed as 1 minus the absolute Pearson correlation coefficient between the two profiles); the y-coordinate
represents the change in magnitude of the response (computed as the difference of the norm of the two profiles). Data from
aerobic (A, top) and anaerobic conditions (B, bottom) are shown. TFs whose response is similar with both CORM-401 and
CO gas, both in magnitude and kinetics, will be located near the origin of each coherence plot in quadrant c, while TFs in
quadrant b of each plot respond differently in both kinetics and amplitude. For example, CpxR, both aerobically and
anaerobically, has a similar response in terms of the shape of the profile, but different magnitudes in (A) and (B), while
ArcA (A) and ArgR (B) show similar magnitudes, but major differences in response profiles. TF, transcription factor.
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the abscissa (x-coordinate) of each point (labeled with the TF
identity) represents the profile difference between the two
conditions, computed as 1 minus the absolute Pearson corre-
lation coefficient between the two profiles, while the ordinate
(y-coordinate) represents the change in magnitude of the re-
sponse (computed as the absolute difference of the norms of
the two profiles). Hence, TFs whose response is similar both in
magnitude and kinetics are located near the origin of the co-
herence plot, while TFs in the top right corner of the plot
respond differently in both kinetics and amplitude.
In this analysis, we identified several key regulators whose
activities underlie the effects described later. Thus, CpxR
appears in quadrants ‘‘a’’ of Figure 5 (A, aerobic and B,
anaerobic), hence exhibiting correlated temporal profiles, but
a large difference in response magnitude. CpxR is a member
of the two-component regulatory system CpxA/CpxR that
combats extracytoplasmic protein-mediated toxicity by in-
creasing the syntheses of the periplasmic protease DegP and
CpxP protein. However, the response regulator Fis, which is
involved in maintenance of nucleoid structure and other
functions, including biofilm formation, motility, and che-
motaxis, is in both quadrants ‘‘c’’ of Figure 5, indicating that
its response is similar in magnitude and kinetics when cells
are exposed to CO gas or CORM-401 in aerobic or anaerobic
conditions. As a further example of the correlation analysis,
the coherence plot also reveals that FhlA (the transcriptional
activator of the formate hydrogenlyase system, quadrant ‘‘d’’
of Fig. 5, top, aerobic) responds similarly in terms of the
activity profile when cells are exposed to CORM-401 or CO
gas, but the magnitudes of the responses are dissimilar and
FhlA does not appear in the anaerobic analysis. (Note that
FlhA, required for flagellar biosynthesis, also appears in these
analyses as a pertinent TF, but its activity is less altered in the
aerobic and anaerobic states.) Each point on the plot has both
horizontal and vertical error bars associated with it, which
take into account the uncertainty in the inferred TF activities
derived from TFInfer. In Figure 5, these error bars have been
omitted to reduce visual clutter; error bars are shown in
Supplementary Figure S2.
CORM-401 perturbs respiratory gene expression. Energy
metabolism was significantly altered, both aerobically and
anaerobically, in response to CORM-401 (Fig. 4). The
TFInfer coherence plot reveals two TFs that regulate genes in
central respiratory metabolism: Fnr (Fumarate Nitrate
Reduction regulator) and ArcA.While Fnr was less perturbed
(being in quadrant ‘‘c’’ of Fig. 5A, B), ArcA responded dif-
ferently under each condition (lying in quadrant ‘‘d’’ of
Fig. 5A, but in quadrant ‘‘c’’ of Fig. 5B). ArcAB, a two-
component system, indirectly senses oxygen, in part, via the
redox state of the quinone pool (1). Under anoxic or micro-
aerobic conditions, ArcB autophosphorylates, then trans-
phosphorylates ArcA through a phosphorelay, increasing the
affinity of ArcA for its DNA targets (26). Phosphorylated
active ArcA (ArcA-P) then represses expression of genes
involved in aerobic respiration (e.g., electron transport en-
zymes, cytochrome bo’, and the Krebs cycle enzymes) and
activates genes involved in fermentative metabolism and
cytochrome bd. Thus, in a mutant lacking oxidase function,
as in the absence of oxygen as electron acceptor, the aerobic
expression of ArcA-P-activated genes such as cydAB is ele-
vated, but that of ArcA-P-repressible genes such as cy-
oABCDE (encoding the heme-copper oxidase) is lowered
(25) because the quinone pool is trapped in a reduced form
and unable to inhibit the autokinase activity of ArcB.
Indeed, Figure 6 shows that CORM-401 mimicked mi-
croaerobic/anaerobic conditions even in the presence of
oxygen; it very strongly increased expression of cydAB (en-
coding cytochrome bd-I) presumably reflecting respiratory
inhibition. Davidge et al. also reported an increase in cydAB
transcripts in response to CORM-3 (9). However, anaerobi-
cally, the cydAB genes were downregulated after 5min. In
contrast, genes encoding the cytochrome bo’-type oxidase
(cyoABCDE) were, under aerobic conditions, transiently
FIG. 6. Differential expression of genes involved in the respiratory chains both aerobically and anaerobically in
response to 67 lM CORM-401. The heat map quantifies the changes elicited in selected genes; the heat scale at the right is
expressed as the natural logarithm of the fold change. To see this illustration in color, the reader is referred to the web
version of this article at www.liebertpub.com/ars
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downregulated by approximately fivefold after 5min. This is
consistent with repression of cyo expression by phosphory-
lated (active) ArcA. Anaerobically, the cyo operon was
consistently downregulated by CORM-401; cyoA was 10-
fold downregulated after 10min. Fold changes relating to
respiratory changes are given in Supplementary Figure S3A.
Figure 6 also shows other respiratory genes. The nuo genes
encode a multisubunit, proton-translocating NADH dehy-
drogenase; all were upregulated by CORM-401 under aero-
bic conditions together with the oxidase genes. The initial
CORM-401-induced increases in cyo expression (0–5min)
and the sustained increase in nuo expression (0–80min) un-
der aerobic conditions are not consistent with the anticipated
repression of these systems by Arc alone; indeed, nuo ex-
pression is regulated in a complex manner not only by ArcA
but also by NarL, Fnr, IHF, and other factors, including C4
dicarboxylates (5). In contrast to the effects of CO gas (69),
expression of ndh, encoding NADH dehydrogenase II, was
upregulated both aerobically and anaerobically for the first 5–
10min after CORM-401 exposure (Fig. 6).
CO released from CORM-401 is targeted to terminal oxi-
dases in vivo. Changes in respiratory gene expression sug-
gested interferencewith respiration, sowe assessedCO targeting
of the oxidases using spectrophotometry on intact cell suspen-
sions. CO bound rapidly to terminal oxidases upon addition of
100lM CORM-401 (Fig. 7A). In the first scan, the 645nm
signal corresponds to the absorbance maximum of CO-ligated
cytochrome d, and the 620nm trough indicates removal of fer-
rous cytochrome d from the difference spectrum (9, 27). Sub-
sequently, a peak at 412nm appeared, suggesting slower binding
of CO to cytochrome o. The developing trough at 442nm has
contributions from the ferrous hemes of cytochromes o, d, and
b595 (27, 56).More slowly formedwere the a/b bands at 540nm,
556nm, and 570nm with contributions from multiple CO-
reactive hemes. Thus, CO is released almost immediately upon
addition to cells and is initially targeted to the cytochrome bd-
type oxidase, coincident with upregulation of cydAB transcripts
in aerobic cells (Fig. 6 and, Supplementary Fig. 3A).
CORM-401 stimulates respiration. In view of the ex-
pected (29) and observed targeting of respiratory oxidases
by CO released from CORM-401 (Fig. 6), we measured di-
rectly the effects of CORM-401 on respiration. Bacterial
membranes were incubated in a chamber closed with a lid
preventing inward diffusion of oxygen so that oxygen con-
sumption decreases dissolved oxygen. Respiration was
stimulated with 6.25mM NADH and followed until *75%
air saturation (shown by the arrow in Fig. 7B), where 100lM
CORM-401 or CO-saturated solution was added. Under these
conditions, CORM-401 inhibited membrane respiration by
up to 32% and equimolar CO gas inhibited respiration by up
FIG. 7. CO released from CORM-401 binds terminal oxidases in whole cells, but exhibits uncoupler-like activity on
respiration. (A) Cells were grown in LB media to the exponential phase and concentrated in PBS to an OD of*55. CORM-
401 was added to a final concentration of 100lM. CO difference spectra were recorded over 15min; arrows show the direction
of absorbance increase or decrease in successive scans. (B) Membrane particles (60lg protein/ml) from wild-type E. coli were
added to a closed electrode chamber. Respiration was stimulated by addition of NADH and when air saturation had reached
*75% of the initial (arrow), CO saturated solution (dashed line) or CORM-401 (final concentration 100lM) was added (gray
dotted line). Respiration of membranes in the absence of any compounds was followed as a control (solid line). (C) Cells were
grown to the mid-exponential phase (OD600nm *0.6) in Evans medium and resuspended in Tris-HCl buffer, pH 7.4, before
analysis in an open oxygen electrode. Where indicated by arrows, glucose was added to stimulate respiration and cells respired
until a steady state was reached before addition of 100lM CORM-401. Inset shows 10lM CCCP added under equivalent
conditions. (D) Partial inhibition of respiration was observed at low oxygen tensions when CORM-401 was added twice
(arrows marked CORM-401). In (C) and (D), KCN was added at the arrows at the end of the experiment to the chamber to a
final concentration of 1mM to fully inhibit respiration. All data are representative of three biological repeats.
10 WAREHAM ET AL.
to 48%. However, the periods of observation were limited by
oxygen depletion from the chamber.
To allow longer observations on intact bacteria, in which the
duration of themeasurement is not limited by the amount of O2
initially present in the liquid, we used thewell-established open
system, allowing inward O2 diffusion to balance oxygen con-
sumption. In such a chamber (Fig. 7C) (10), the respiration rate
at steady state is proportional to the difference between the
equilibrium concentration of O2 and the steady-state concen-
tration of O2 in solution; in contrast, in a closed system
(Fig. 7B), the respiration rate is proportional to the negative
slope of the plot of O2 concentration versus time. To stimulate
respiration, glucose was added (Fig. 7C), whereupon the
equilibrium concentration of O2 fell. Respiration was followed
at a constant stirring speed (and thus oxygen transfer rate)
adjusted to give a near-steady state around 50% air saturation.
When 100lM CORM-401 was added to the chamber
(Fig. 7C), respiration clearly increased as evident in the further
fall in dissolved O2 concentration. This pattern resembles in-
creases in respiration rates induced by substrate provision in
Klebsiella (10). A similar increase in respiration rate was ob-
served (28) when this concentration of CORM-401 was added
to endothelial cells. The theory for O2 transfer into a suspension
culture is well known [for references, see (10)]: provided that
the liquid–gas interface surface area is constant, the rate of O2
transport from the gas to the liquid is given by v=KLa(TG-TL),
where v is the rate of respiration,K is a constant that depends on
the experimental volume, surface area, and temperature, TG is
the molar concentration of O2 in the liquid when equilibrated
with air, and TL is the O2 concentration in the liquid. In the
nonproliferating cell suspensions used here, the slow decline in
dissolved O2 after a near-steady state was reached was ne-
glected. We measured a KLa (11) of 0.23min
-1 (SD 0.06, 10
measurements) and a glucose-stimulated respiration rate of
215 nmol O2.min
-1.mg-1 (SD 78, 13 measurements).
In the experiment shown in Figure 7C, respiration in-
creased by 50 % after adding 100lM CORM-401, typical of
numerous experiments. This increase is similar to that ob-
served before (28, 52). As a control, 1mM KCN (a potent
respiratory inhibitor) was added to the chamber (Fig. 7C)
when steady state had been reached after adding CORM;
dissolved oxygen then increased abruptly to prerespiration
levels, indicating respiratory inhibition as expected. This
pattern resembles decreases in the respiration rate induced by
substrate exhaustion in Klebsiella (10). The CORM 401-
stimulated oxygen consumption can be assigned to cellular
respiration since it is cyanide sensitive. The stimulation by
CORM-401 was further investigated by using the same cell
suspension (as Fig. 7C), but 10 lM carbonyl cyanide m-
chlorophenyl hydrazone (CCCP), a classical uncoupler of
respiration, was added to the chamber (Fig. 7C, inset). CCCP
mimicked the effects of CORM-401; thus, both compounds
stimulate oxygen consumption rates of E. coli cells.
In these experiments, dissolved oxygen was >50% satu-
ration (*100lM) at the point of adding CORM. However,
maximal inhibition of respiration typically occurs at high
CO:O2 ratios since CO is a competitive inhibitor of terminal
oxidases with oxygen; CO:O2 ratios of 4:1 to 20:1 are used in
photochemical action spectra (6). Thus, to maximize the
potential inhibition of respiration by CORM-401, the stirring
rotor speed was decreased to achieve a lower (but not zero)
oxygen concentration in the chamber after stimulating res-
piration with glucose (Fig. 7D). On adding CORM-401, a
very small transient inhibition was seen. A second addition of
100lM CORM-401 (arrow 2) produced mild, but prolonged,
inhibition. To confirm these findings, 1mM KCN was again
added to the chamber and substantial inhibition followed. In
the experiments of (28), 300lM CORM-401 was required to
inhibit respiration by endothelial cells. In summary, CORM-
401 is not an effective inhibitor of respiration, even at low
oxygen tensions, but stimulates respiration; such stimulation
was described as uncoupling in endothelial cells (28).
FIG. 8. CORM-401 and the classical uncoupler CCCP
cause polarization of the membrane in whole cells. E. coli
cells were grown to the exponential phase and resuspended
in 5mM HEPES buffer to a final OD600 of 0.6. Cells were
incubated with 0.1 M KCl and 10mM glucose before in-
cubation with 0.4 lM DiSC3(5). Additions were as follows:
(A) 1 lM valinomycin (val); (B) 50 lM CO (solid line) or
buffer (dotted line); (C) 50 lM CORM-401; and (D) 1 lM
CCCP; Trace (E) shows additions of 1lM valinomycin,
followed by 50lM CORM-401; (F) shows additions of 1lM
valinomycin and then 1lM CCCP. Results are representative
of three independent biological repeats, where net changes in
fluorescence were equivalent across all repeats. Fluorescence
changes (DF) are expressed as arbitrary units (AU). CCCP,
carbonylcyanide m-chlorophenylhydrazone.
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CORM-401, like CCCP, polarizes the membrane in whole
cells. CCCP and other protonophores (uncouplers) have
dissociable protons and permeate membranes either as pro-
tonated acids or conjugated bases; they therefore facilitate
proton exchange across energy-transducing membranes (43).
To extend the understanding of energetic implications of
CORM-401 administration, we measured membrane potential
in whole cells using DiSC3 (5, 61). DiSC3(5) is a cationic
cyanine dye that responds fluorometrically to changes in
membrane potential by potential-dependent partition between
the cells and the extracellular medium. When a cell or mem-
brane interior becomes negatively charged (polarized), the dye
is taken up with consequent fluorescence quenching (61).
Depolarization, on the other hand, results in release of the dye
and increase in fluorescence. The negatively charged interior
of respiring E. coli cells led to uptake of the dye and slow
fluorescence quenching; to collapse the membrane potential
(Dw) and depolarize the membrane, K+ and the K+-specific
ionophore valinomycin were added (Fig. 8A), whereupon net
movement of the dye out of the cells resulted in increased
fluorescence. However, a solution of CO (50lM final con-
centration) did not significantly alter DiSC3 (5) fluorescence
(Fig. 8B). In marked contrast, addition of 50lM CORM-401
(Fig. 8C) or only 1lM CCCP (Fig. 8D) led to sustained de-
creases in fluorescence over 15min, demonstrating polariza-
tion of the membrane. Thus, both CORM-401 and CCCP
stimulate respiration (Fig. 7) and increase polarization of the
membrane (Fig. 8) (see the Discussion section). To determine
whether membrane polarization was mediated by potassium
flux across the membrane, the potassium gradient was first
collapsed by valinomycin (Fig. 8E), followed by additions of
CORM-401 (Fig. 8E), or valinomycin followed by CCCP
(Fig. 8F). Addition of valinomycin caused a net movement of
DiSC3 (5) out of the cell, as in Figure 8A, but when CORM-
401 or CCCP was then added, polarization of the membrane
was evident from the drop in fluorescence. In the case of
CCCP, dramatic polarization was observed (an initial fluo-
rescence decrease) as the collapse of the potassium charge
gradient no longer impedes proton movement. The slower
subsequent rise in fluorescence is attributed to a slow H+ leak
after initial hyperpolarization by CCCP. Therefore, polariza-
tion caused by CORM-401 and CCCP is potassium indepen-
dent, suggesting involvement of H+ or another cation.
Genes involved in potassium and general ion homeostasis
and osmolarity are perturbed in response to CORM-401. In
accord with the observed respiratory stimulation and mem-
brane polarization elicited by CORM-401 (above), tran-
scriptomic studies highlighted numerous genes involved in the
transport of potassium and zinc and genes involved in osmo-
regulation and ion homeostasis (Fig. 9). The KdpFABC com-
plex is a multisubunit ATP-driven potassium pump (24). All
four genes encoding the membrane transporter were upregu-
lated within 5–10min after CORM-401 treatment under aero-
bic conditions (Fig. 9). The kdp genes are expressed when K+
levels in the cell become limited (33); this expression is regu-
lated by KdpD (sensor kinase) and KdpE (response regulator)
comprising a two-component regulatory system. However,
measurements of membrane polarization in the presence of
valinomycin (Fig. 8) show that CORM-401-elicited polariza-
tion is independent of potassium gradients, and so it is likely
that the changes in kdp gene expression reflect global osmotic
changes (30, 34) and/or the physicochemical state of the
membrane, as induced by ethanol, procaine, and others (66). In
addition to this high-affinity potassium transport system, chaA,
encoding a K+/Na+:H+ antiporter, was also transiently upre-
gulated both aerobically and anaerobically (Fig. 9). E. coli
possesses two other K+ transport systems, namely Kup and Trk,
FIG. 9. Differential expression of gene involved in osmoregulation. The heat map quantifies the changes elicited in
selected genes both aerobically and anaerobically in response to 67lM CORM-401. The heat scale at the right is expressed
as the natural logarithm of the fold change. To see this illustration in color, the reader is referred to the web version of this
article at www.liebertpub.com/ars
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which exhibit a high transport velocity, but low affinity, and
these are constitutively expressed, as evidenced by the invariant
levels of trkA expression (Fig. 9).
Two possible Ca2+ transporters have been identified in
E. coli, including a Ca2+/H+ exchanger, ChaA, but it appears
not to be a major Ca2+ efflux pathway (42); the chaA gene
was upregulated by CORM-401 after 5min both aerobically
and anaerobically, further implicating osmotic imbalance
(Fig. 9). ChaA has also been identified as a K+/H+ antiporter
with roles in potassium homeostasis (54).
Other systems involved in osmoregulation were perturbed
by CORM-401. Mechanosensitive channels are membrane
transporters that respond to changes in cellular osmotic
pressure (65). MscS is a homoheptameric archetypal member
of a diverse superfamily of mechanosensitive channels. It
possesses a large water-filled cytoplasmic domain, is involved
in selectivity, and may function as a cytoplasmic osmometer
(47). In response to CORM-401, mscS was up to fivefold up-
regulated both aerobically and anaerobically (Fig. 9), sug-
gesting osmotic stress, perhaps due to uptake of the CORM.
We observed striking downregulation (to undetectable
levels; Supplementary Fig. S3B) of the ompF gene encoding
a large trimeric membrane permeability channel. The ex-
pression of this porin and of the other major porin OmpC is
exquisitely regulated (45). Because noxious agents such as
antibiotics diffuse more readily through the larger OmpF
channel, its increased production also facilitates entry of
nutrients. Environmental osmotic status is sensed by the
EnvZ component of the EnvZ-OmpR two-component sys-
tem. High osmolarity activates OmpR, and ompC expression
is increased and ompF expression decreases. The present data
thus point to bacterial sensing of increased osmotic pressure.
The OmpC and OmpF channels appear differentially regu-
lated to tackle changes in osmotic pressure; OmpF may be
downregulated to avoid mass movement of unwanted solutes
into the cell, including the CORM-401 compound itself,
while expression of the smaller channel, OmpC, allows finer
control of solute movement. Other systems that control turgor
pressure include the aquaporin aqpZ, a water channel that
allows the bidirectional movement of water in response to
osmotic stress (62). This channel was slightly downregulated
in aerobic conditions in response to CORM-401 (Fig. 9).
Expression of a zinc-binding subunit of a zinc transporter
(znuA) (51) was also upregulated by 11-fold after 20min
aerobically (Fig. 9); anaerobically, a delayed rise peaked at
sevenfold upregulation after 40min.
CORM-401 leads to changes in cellular potassium and
zinc levels. Informed by the transcriptomic changes that
indicated perturbation of metal ion homeostasis or osmolarity
and the demonstration that CORM-401 leads to membrane
polarization, we measured potassium fluxes using sphero-
plast swelling experiments. Potassium movements with
consequent swelling in the presence of CORMs have already
been shown with CORM-3 (73), but CORM-401 did not in-
duce spheroplast swelling in the presence of iso-osmotic
potassium nitrate/potassium nitrite (data not shown). Al-
though passive potassium movements appear not to be in-
voked by CORM-401, other data (above; upregulation of kdp
and downregulation of potassium efflux machinery) sug-
gested that bacteria experienced potassium limitation. We
therefore assessed the levels of total intracellular potassium
and trace metals in the presence of CORM-401 using ICP-
MS. Figure 10 shows that 67lM CORM-401 decreased the
intracellular concentration of potassium and zinc by about
threefold over 40min. There were no measurable changes of
copper or iron levels in response to CORM-401 addition, nor
were genes implicated in themetabolism of these altered ions.
CORM-401 causes induction of the Cpx and Bae regulons,
altering the expression of Spy and CpxP proteins, but without
measurable membrane damage to cells. The Cpx system
in E. coli protects the membrane during stress (55), such as
high osmolarity, leading to the management of cellular pro-
cesses that include motility, chemotaxis (13), and biofilm
formation (14). Exposure of cells to CORM-401 upregulated
numerous genes under the transcriptional control of Bae/Cpx
(Fig. 11). Genes encoding the multidrug efflux system (mdtA-
D) were more than 60-fold upregulated under both aerobic
FIG. 10. Potassium and zinc levels fall after CORM-
401 addition. E. coli cells were grown to the exponential
phase in Evans medium supplemented with 20mM glucose.
Samples were taken immediately before (t = 0) and at time
intervals after 67lMCORM-401 addition (final concentration).
Cell pellets were analyzed using ICP-MS. (A) Intracellular po-
tassium and iron levels; potassium falls significantly between
t=0 and t=80 (p=0.03). (B)Zinc and copper levels; zinc levels
fall between t= 0 and t=80. n=3–SEM. ICP-MS, inductively
coupled plasma mass spectrometry.
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and anaerobic conditions (Supplementary Fig. S3C). Upre-
gulation of the Cpx response by CORM-2 (46) and involve-
ment of the Cpx and Bae systems in response to CORM-3
have been noted previously (9, 38). The most dramatic per-
turbation was that of the periplasmic chaperone Spy, which
was upregulated by >400-fold aerobically and >600-fold
anaerobically (Supplementary Fig. S3C); CORM-3 elicits
similar changes (9, 38).
To determine whether the increased transcripts reflected
protein levels, Western blot assays were carried out using
FIG. 11. Differential expression of genes implicated in general stress responses, metal ion stress, and cell envelope
stress. The color-scale bar shows mean fold changes in individual genes of WT E. coli both aerobically and anaerobically in
response to 67lM CORM-401. The heat scale at the right is expressed as the natural logarithm of the fold change. To see
this illustration in color, the reader is referred to the web version of this article at www.liebertpub.com/ars
FIG. 12. CORM-401 leads to upregulation of cellular stress responses, but does not perturb the outer membrane of
E. coli. (A) Coomassie-stained SDS gel of soluble fractions used in Western blotting illustrates equal loading of protein.
Molecular mass markers (kDa) are shown on the left. (B) A typical Western blot of subcellular fractions is shown in the
absence (lane 1) and presence of 67 lM DTC/MnSO4 (lane 2) or 67 lM CORM-401 (lane 3) for 2 h with anti-CpxP and anti-
Spy antibodies. Data shown are representative of three biological replicates. (C) Cells were resuspended in PBS, then
exposed to NPN alone (black bar), NPN +3% triton (positive control) (gray bar), or 100 lM CORM-401 for increasing time
periods (as labeled). All concentrations given are final concentrations in the fluorescence cuvette. n= 3 – SEM.
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antiserum samples to two key players in the response, Spy
and CpxP (74). Spy was detected in periplasmic fractions of
wild-type cells and CpxP was measured in total soluble
(cytoplasmic and periplasmic) fractions. Addition of 67lM
CORM-401 significantly increased Spy protein levels after
2 h (Fig. 12B, lane 3), whereas incubation with the control
compounds MnSO4 and DTC did not raise Spy to detectable
levels (Fig. 12B, lane 2); the control in the absence of CORM
showed no detectable Spy levels (Fig. 12B, lane 1). Levels of
the periplasmic chaperone CpxP were clearly detected in the
absence of CORM (Fig. 12B, lane 1) and also on incubation
with control compounds (Fig. 12B, lane 2), but a significant
decrease in CpxP abundance was seen after 2 h of CORM-
401 treatment (lane 3). The CORM-induced decrease in
CpxP is consistent with literature on the Cpx response (55);
since CpxP is a negative regulator, its levels are lowered to
achieve the Cpx response evident in Figure 11.
CORM-3 upregulates spy expression and increases Spy
levels due to membrane damage (74). The effects of CORM-
401 on bacterial outer membranes (OMs) were therefore
assayed using N-phenyl-1-napthylamine (NPN), a membrane-
impermeable fluorophore that increases fluorescence in a
hydrophobic environment (61). Thus, when the bacterial
membrane becomes perturbed (e.g., by an antibiotic or
CORM-401), the dye partitions into the outer membrane,
leading to an increase in fluorescence. Interestingly, the ad-
dition of CORM-401 to cells in the presence of NPN showed
no increase in membrane damage, even after several hours
(Fig. 12C). The detergent Triton X-100 was used as a positive
control (Fig. 12C). Thus, the action of CORM-401 is distinct
from CORM-3: the upregulation of Spy protein and transcript
levels by CORM-401 appears indirect and due to perturbation
of cellular osmotic balance and metal ion homeostasis.
The spy gene is positively regulated by phosphorylated
CpxR, whereas several motility genes are negatively controlled
(13). Indeed, Figure 4 shows that on incubating bacteria with
CORM-401 for 5 or more min, the expression of motility genes
was decreased. However, within the first 5min of exposure to
CORM-401 or after 80min of incubation, amajority ofmotility
genes were upregulated (Fig. 2). To resolve this, we measured
FIG. 13. A growth screen of pathogens isolated from clinical infections shows varying susceptibility to CORM-401.
Strains were grown in Evans medium with glucose to the early exponential phase before the addition of 500 lM CORM-401
(closed circles, addition indicated by arrows) or the equivalent volume of PBS (open circles). Growth was monitored
throughout, n = 3– SD.
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motility (swarming) as before (38). After 48 h of incubation, the
mean colony diameters were measured as 12.2 (–2.2 SD) mm
for control colonies, whereas cells grown with 67lM CORM-
401 (as used for Fig. 4) had an increased colony diameter of
24.2 (–0.8 SD) mm (data not shown). However, control com-
pounds Mn(II) sulfate and sarcosine DTC increased motility
further (colony diameter of 32.3– 2.3 SD mm). Student’s t-test
revealed that the difference between these data sets was highly
significant ( p-value <0.001). We conclude that bacterial mo-
tility is not modulated by intact CORM-401.
A CORM-401 growth screen of several pathogens isolated
from clinical infections shows varying susceptibility. To
broaden the significance of this study, eight clinical isolates
of pathogenic bacteria were tested for their sensitivity to the
title compound. E. coli EC958 is a multidrug-resistant
O25b:H4 clinical pathogen (68). The genome encodes nu-
merous putative virulence factors, including siderophore re-
ceptors and autotransporters, and bears genes conferring
resistance to ciprofloxacin and other antibiotics (68). We also
tested clinical isolates of Klebsiella pneumoniae, Shigella
flexneri, Pseudomonas aeruginosa, Salmonella enterica ser-
ovar Kedougou, Enterobacter hormaechei, Citrobacter ko-
seri, and Acinetobacter baumannii. Cultures were grown to
early exponential phase before the addition of CORM-401
(final concentration, 500 lM). Growth was monitored until
the stationary phase was reached in cultures not exposed to
the compound (Fig. 13). Addition of the metal carbonyl
caused a complete arrest in growth forK. pneumoniae, E. coli
EC958, S. flexneri, S.Kedougou, and E. hormaechei cultures;
however, growth of P. aeruginosa, C. koseri, and A. bau-
mannii was unperturbed by the compound.
CORM-401 toxicity in combination with antibiotics. A
promising approach to the rise of antibiotic-resistant bacteria,
compounded by slow emergence of new drugs, is the use of
nonantibiotic compounds to complement existing antibiotics
(15, 20). While antibiotics generally target specific cellular
processes, such as DNA replication and synthesis of cell walls
and proteins, CORMs have numerous targets, as evidenced
here. Thus, we tested CORM-401 interactions with two anti-
biotics, cefotaxime and trimethoprim, against strain MG1655.
Addition of 100lM CORM-401 with antibiotics at sublethal
doses led to a greater statistically significant reduction of
growth compared with either the antibiotic or CORM-401
alone (Supplementary Fig. S4A, B). However, viability assays
with cefotaxime (Supplementary Fig. S4C) or trimethoprim
(Supplementary Fig. S4D) showed that each antibiotic and
CORM-401 significantly reduced viable cell numbers, even
when used individually. To quantify these interactions, we
used checkerboard dilution plates and calculated the fractional
inhibitory concentrations (FICs) for each combination. For
cefotaxime and trimethoprim (Supplementary Fig. S4) as well
as for novobiocin and cefotaxime, FIC values were between
0.54 and 0.91 (Table 1), indicative of no interaction (48) be-
tween the two antimicrobial compounds.
The World Health Organization, in its recent global pri-
ority list of antibiotic-resistant bacteria, identifies antibiotic-
resistant Enterobacteriaceae, including E. coli, as being
among the most critical (71). Because of the broad antibiotic
resistance of strain EC958, we selected colistin (a drug of last
resort), doxycycline, and gentamicin. In each case, FIC val-
ues were between 0.56 and 1.03 (Table 1), again indicative of
no interaction between the two antimicrobial compounds. In
conclusion, the bactericidal and bacteriostatic activities of
CORM-401 are not synergistic with antibiotic action.
Discussion
CORMs, originally devised to mimic the beneficial anti-
oxidant, anti-inflammatory, and cytoprotective benefits of
CO, serendipitously proved to be effective antimicrobial
agents. In particular, the ruthenium compounds CORM-2 and
CORM-3 are highly effective antimicrobials (12, 73), but the
basis of their efficacy remains unresolved. CO release ap-
pears to be a minor contributor to microbial toxicity and
attention has turned to the role of Ru (63).
Interestingly, a manganese photoactivated CORM,
([Mn(CO)3(tpa-j
3N)]+), is less effective than the Ru com-
plexes (41), unless combined with hydrogen peroxide (67).
The present compound, CORM-401, is also a manganese
complex, on which few studies are published. In previous
work, it released 2.1–3mol CO in the myoglobin assay (16),
in line with our determination of 2.4–2.5mol in minimal
growth medium or phosphate buffer and with myoglobin at a
Table 1. Interactions of CORM-401 with Antibiotics Having Different Modes of Action
Antibiotic FICantibiotic
a FICCORM
b
+FIC =FICantibiotic +
FICCORM
CORM/antibiotic
interaction
Escherichia coli strain MG1655
Doxycycline 0.25 0.66 0.91 No interaction
Trimethoprim 0.12 0.42 0.54 No interaction
Novobiocin 0.33 0.33 0.66 No interaction
Cefotaxime 0.12 0.66 0.78 No interaction
E. coli strain EC958
Colistin 0.5 0.06 0.56 No interaction
Doxycycline 0.5 0.13 0.63 No interaction
Gentamicin 1.0 0.03 1.03 No interaction
FIC values (calculated as described in the Materials and Methods section) are shown for CORM-401 in combination with the selected
antibiotics. MIC values are expressed as lg ml-1. The description of the interaction follows the recommendation of odds (48).
aMIC of antibiotic in combination/MIC of antibiotic alone.
bMIC of CORM in combination/MIC of CORM alone.
CORM, carbon monoxide-releasing molecule; MIC, minimal inhibitory concentration; FIC, fractional inhibitory concentration.
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fourfold excess over CORM-401. In mammalian studies, the
higher CO yield elicited more effective aortic relaxation and
vasodilation than did CORM-A1, which has a similar half-
time of CO release, but a lower molar CO yield. CORM-401
reduces inflammation and damage in pig kidneys in a pre-
clinical model of organ donation (3) and reverses the meta-
bolic changes that occur during lipopolysaccharide-induced
microglia inflammation (72).
In endothelial cells, there is evidence that the CO released
from CORM-401 uncouples mitochondrial respiration and
inhibits glycolysis (28) since inactive CORM-401 (iCORM)
(actually a mix of MnSO4 and the CORM-401 ligand DTC)
did not induce these effects. However, even 300lM CORM-
401 elicited only twofold elevation in the oxygen consumption
rate, whereas only 1lM CCCP gave greater stimulation (28).
CORM-401 therefore exerts relatively weak, but clear
uncoupler-like, activity inmammalian cells, a result confirmed
here in bacteria (Fig. 7C). In endothelial cells, CORM-401 also
reactivated mitoBKCa channels after blockage with paxilline
(28). The mechanistic basis of most of these effects on mito-
chondria is unclear, but it is assumed that at the highest CORM
concentrations, the decrease in respiration rate is due to inhi-
bition of cytochrome oxidase activity (28). Activation of mi-
tochondrial uncoupling proteins has been proposed to explain
CORM-3-uncoupled metabolism in cardiomyocytes (36).
Our data suggest an alternative mode of action for growth
inhibition of E. coli (Fig. 1) and many other bacteria (Fig. 14)
and the myriad effects of CORM-401. First, the released CO
does target terminal oxidases (Fig. 7A) leading to slight re-
ductions in oxygen consumption rates (Fig. 7B, D), but the
stimulatory effects on respiration are much more significant
(Fig. 7C). In-depth transcriptomic and modeling studies
(Figs. 4–6) confirm effects on respiratory gene regulation.
More striking are the elevations in intracellular Mn concen-
trations (and thus the CORM, Fig. 3). We suggest that buildup
of the metal co-ligand fragment in the cytoplasm to millimolar
concentrations leads to disruption of charge (Fig. 8) and ion
balance (Fig. 10) and the perception by the cell that it is un-
dergoing osmotic stress (Figs. 9, 11, 12). These ideas are
summarized in Figure 14. The mechanism of polarization
caused by CORM-401 is unclear, but is independent of po-
tassium gradients (Fig. 8) and presumably caused by pertur-
bation of other ionic balances across the membrane. In
mammalian systems also, the CORM-401-enhanced resistance
of cardiomyocytes to oxidative stress may be, at least in part,
due to the manganese center (31). However, in contrast to (28),
we cannot attribute the effects onmembrane polarization to the
released CO since a CO gas solution is without effect on
membrane potential (Fig. 8B). Our proposals that CORM-401
toxicity is not dependent on respiratory inhibition are in accord
with other studies, notably the finding that CORM-3 is toxic to
bacteria even in the absence of a heme target (74).
CORM-401 stimulates mitochondrial (28) and bacterial
[(73); this work] respiration, a response mimicked by the
FIG. 14. Schematic diagram of a hypothesis for the antimicrobial effects of CORM-401. CORM-401 (structure
shown at bottom left), administered extracellularly, is transported inward to the cytoplasm either by diffusion (1) or by an
unidentified transporter (2). Within the cell, CO is released (3) leaving a metal co-ligand fragment (iCORM). CORM
accumulates to very high levels (4), perhaps as a result of the maintenance of a concentration gradient, following conversion
of the CORM (outside) to iCORM (inside). CORM-401 and/or its breakdown products elicit major transcriptional changes
(5), reflected in altered protein synthesis/function. CO, whether released from CORM within cells or following gas diffusion
from outside (6), binds to oxidases (O) and partly inhibits aerobic NADH oxidation via flavins (F) and quinones (Q) (7).
This perturbs the protonmotive force, which is matched by enhanced respiration leading to membrane polarization, which in
turn drives further uptake. Translocation of cations (Mn+) such as K+ or Zn(II) is shown (8).
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classical uncoupler CCCP (Fig. 7C). However, the fact that
CORM-401, like CCCP, caused polarization of the mem-
brane (Fig. 8) suggests that this is compensated by enhanced
respiration. That bacteria remain viable after CCCP treat-
ment and can mount such a respiratory response is evidenced
by the fact that neither 100lMCORM-401 (this work, Fig. 2)
nor 1 lM CCCP significantly inhibits growth and respira-
tion remains responsive to imposed membrane conditions.
Indeed, 1 lM CCCP elicits only a 2% decrease in swimming
speed of E. coli (4).
CORM-401 has a net negative charge in solution, yet is
rapidly accumulated to millimolar levels in the cell (Fig. 3A).
The charged metal species produced when the compound
releases CO might also affect charge separation across the
membrane. It is expected that when CO groups are released
from CORM-401, the metal in the residual co-ligand frag-
ment will become oxidized giving an Mn(II) species. It is
therefore interesting that upon CORM-401 addition, cells
become polarized; this may be due to perturbation of charge
separation across the membrane or by accumulation of
compatible solutes, with little or no negative charge, to bal-
ance the influx of positive charge (75). In addition to polar-
ization, loss of K+ and Zn(II) from the cell (Fig. 10) may
result from accumulation of charge. The mechanosensitive
channel, MscS, which is upregulated in response to osmotic
pressure, was also upregulated (Fig. 9). We suggest that a
contributing factor to the action of CORM-401 is generation
of high osmotic pressure upon extreme accumulation of the
compound (Fig. 3). Although cellular envelope stress re-
sponses are upregulated at the transcriptomic and protein
levels, and transport systems for metal ions and water are
differentially expressed in response to CORM-401 (Fig. 8),
CORM-401, unlike CORM-3, has little effect on the cell
membrane as assessed by NPN fluorescence.
In this study, we demonstrate for the first time that CORM-
401 also has broad-spectrum antimicrobial activities. How-
ever, CORM-401 exhibits toxicity toward eukaryotic cells: at
100 lM, a 25% decrease in viability of RAW264.7 cells was
noted (7), whereas this concentration had little effect on
E. coli viability up to 4 h (Fig. 2C, D). CORM-401 toxicity is
dependent on the carbon source used in the growth of the
bacterium, probably reflecting differences in uptake (Fig. 3).
Although CO released from CORM-3 and ([Mn(CO)3(tpa-
j3N)]+) binds cellular targets such as respiratory heme oxi-
dases, recent data suggest that CORMs display numerous
other modes of toxicity.
The multiple modes of action of CORM-401 and other
CORMs are clearly distinct from the focused effects of most
antibiotics, suggesting that these compounds, even before
we comprehensively understand their targets, should be
valuable as antimicrobial agents that could enhance antibiotic
sensitivities. Indeed, CORM-401 enhances, without interac-
tion, the efficacy of four antibiotics on E. coli (Table 1). It is
notable that CO gas neither potentiates the toxicity of anti-
biotics nor protects from their effects (69).
The different sensitivities of clinical isolates to CORM-
401 probably reflect different metabolism and import/export
mechanisms. The resistance of P. aeruginosa to CORM-401
appears contrary to the results of previous research using
CORM-2 (40). However, P. aeruginosa and A. baumannii
express multiple efflux pumps, making them resistant to
numerous antibiotics (19, 64). The hypothesis that these
strains fail to accumulate CORM-401 intracellularly might
be tested by analyses of manganese contents and comparison
of sensitive and resistant strains. Resistance to CORM-401
may also reflect the ability of resistant bacteria to produce and
excrete mucoid substances forming a peripheral capsule
around the pathogens, hindering access of the metal carbonyl
compound. Capsule production decreases sensitivity to an-
tibiotics and renders pathogens resistant to phagocytosis by
macrophages and to the toxic effects of free radical species
(21, 22). The potential for CORMs to act as novel antimi-
crobials against other clinical isolates is indicated by the
sensitivity of numerous bacterial species, including several
members of the family Enterobacteriaceae. For example, the
sensitivity of the urinary tract and bloodstream pathogen
E. coli EC958 to CORM-401 suggests that exploration of
these CO releasers as potential anti-UTI drugs either alone or
with current antibiotics is a realistic possibility.
An ongoing challenge is to understand the bases of the
antimicrobial actions of CORMs and use this knowledge to
devise scaffolds with increased activity. Although CORM-
401 is a less effective antimicrobial agent than CORMs-2 or
-3, such data contribute to our understanding of the effects of
CORMs in general and the development of future CORMs as
antimicrobials; greater consideration of the effect of the
metal center could lead to the generation of more potent and
biologically compatible CORMs.
Materials and Methods
E. coli strains and batch growth conditions
E. coli K12 derivative MG1655 was used as a model or-
ganism for this study; other pathogenic clinical isolates were
tested where indicated. All strains were grown in Evans
medium with glucose or succinate (20mM each) as the car-
bon source (27). For S. flexneri and A. baumannii, MEM
amino acid (50· –Sigma-Aldrich) solution was added to fa-
cilitate growth. Unless stated, cells were grown to the mid-
exponential phase (OD600 * 0.5–0.6, 50–60 Klett units)
before adding CORM-401 or other compounds. Growth was
monitored using a Klett-Summerson colorimeter using a red
filter in 250-ml conical flasks fitted with side arms or spec-
trophotometrically at 600 nm. Note that bacterial cultures
begin growth at different intervals after inoculation, so av-
eraging several similar experiments on a time basis is inap-
propriate. Growth curves generally show one experiment
representative of three or more that showed similar kinetics
and growth rates.
Chemostat growth conditions
For continuous culture, cells were grown in an Infors
Multifors bioreactor (total volume 200ml) adapted to fit a
Labfors-3 fermenter base unit. Temperature was maintained
at 37C with continuous stirring at 200 rpm; the dilution rate
was 0.2 h-1. Mass flow controllers allowed gas mixes for
aerobic and anaerobic conditions to be maintained by con-
tinuous bubbling at 100ml min-1 with air and N2 gas (aero-
bic) or N2 gas alone (anaerobic) as before (38).
CORM-401 and control compounds
CORM-401 was synthesized in the Department of Chem-
istry, The University of Sheffield, as before (7). Stock
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solutions (5mM) were prepared fresh daily in phosphate-
buffered saline (PBS), pH 7.4. There is no useful iCORM, that
is, an inactive compound for control experiments; instead,
MnSO4 (0.1 M stock solution) and sodium dithiocarbamate
(DTC, Na[S2CN(CH3)CH2COONa], 10mM stock solution)
were combined to give equimolarmixes of the two compounds,
as required. Once the Mn in CORM-401 loses CO, Mn(I) will
probably be oxidized toMn(II). Mn(II) is kinetically labile and
it is probable that the [O2CCH2NMeCS2]
2- ligand dissociates.
Others refer to such a mixture as inactive CORM-401 (16), but
its physiological and transcriptomic effects have not been
evaluated.
Myoglobin assay for CO release
CO liberated from CORM-401 was assayed using the re-
action with ferrous myoglobin (39), but final concentrations
of myoglobin and CORMwere 15 lM and 3 lM, respectively
(to allow equistoichiometric binding to myoglobin of the
anticipated 3–4mol CO released from CORM-401). All as-
says were carried out at 37C unless otherwise indicated.
Subcellular fractionation and metal analyses
Exponential cultures (1 L) were supplemented with 67lM
CORM-401 or, as a control, DTC/MnSO4 and incubated
at 37C with shaking at 200 rpm for 90min before centrifu-
gation (10min, 12,000 g). The supernatant was retained
for analysis and the cell pellet was resuspended in *6ml
of 200mM PBS (pH 7.0) before sonication on ice (MSE
Soniprep, 16lm, 6 · 15 s bursts). Following centrifugation
(20min, 20,000 g), the pellet comprising cell debris was
discarded. From the supernatant, membrane and cytoplasmic
fractions were isolated by ultracentrifugation (60min,
160,000 g) using centrifuge tubes prewashed in concentrated
nitric acid to remove trace metals. Samples of genomic DNA
were isolated from independently grown cultures under
identical growth conditions using the Wizard Genomic
DNA Purification Kit and the manufacturer’s instructions.
Metals were assayed in all fractions by inductively coupled
plasma mass spectrometry, as described below.
Assay of CO binding to cellular heme proteins
Spectra were recorded with an Olis RSM1000 dual-beam
rapid scanning monochromator (On-Line Instrument Sys-
tems) fitted with a clarity accessory as before (56). Cells were
resuspended in PBS to an OD *55 and CORM-401 was
added to a final concentration of 100 lM. Scans were taken at
intervals up to 15min after addition of CORM-401.
Assays of cellular respiration
In closed electrode experiments, oxygen consumption was
measured using a Clark-type electrode (27) (Rank Brothers,
Bottisham, Cambridge, United Kingdom). The chamber
contents (2ml) were stirred at 37C, while the top was sealed
with a close-fitting lid that permitted addition via micro-
syringes of reagents. For prolonged measurements of respi-
ration, a custom electrode apparatus open to the atmosphere
based on published designs (11) was used. The Perspex cell
(working volume 4ml) was maintained at 37C by circulat-
ing water, the cell being constructed of stainless steel to aid
temperature equilibration. The two-bladed stirring impeller
(diameter 14mm) was mounted on a stainless steel shaft that
was stirred using an overhead stirrer (IKA-Werke Eurostar
power control-visc P4) to maintain a stable vortex and ab-
solute constancy of rotational speed and therefore of transfer
of air from the atmosphere to the stirred sample. The rate of
oxygen diffusion from the atmosphere to the sample was
expressed as KLa, measured as in (52). The additions made
were of CORM-401 (stock solution 5mM), carbonyl cyanide
m-chlorophenylhydrazone (CCCP; stock solution 10mM), or
KCN (stock solution 15mM).
Assays of membrane potential
Cells were washed, resuspended in 5mMHEPES buffer to
a final OD600 of 0.6, and incubated with 0.1 M KCl and
10mM glucose before treatment for*5–10min with 0.4 lM
DiSC3(5) in a 3-ml quartz cuvette. Fluorescence was mea-
sured as before using a Hitachi F-2500 fluorescence spec-
trophotometer.
Assays of cell motility
Motility assays were performed as previously described
(38). Briefly, E. coliMG1655 cells were aerobically grown to
the stationary phase in glucose-supplemented Evans medium
and 10 ll of the liquid culture was spotted onto 0.3% (w/v)
LB/agar plates containing 67 lM CORM-401 or the control
compounds DTC/MnSO4. Plates were incubated for 48 h at
30C and colony diameters measured. Each of 3 biological
replicates comprised five technical determinations.
Transcriptomic analysis and statistical modeling
These procedures were conducted as before (38, 69, 74)
except that samples were taken from chemostat cultures of
glucose-grown cells immediately before CORM-401 addi-
tion and at intervals thereafter. In brief, extracted RNA was
labeled with Cy-3 or Cy-5-dCTP and hybridized to Agilent
arrays that were scanned using an Agilent DNA Surescan
Microarray scanner with subsequent feature extraction and
data analysis using GeneSpring GX v7.3. Arbitrary values
of ‡2-fold (i.e., ‡2-fold increased expression) or £0.5-fold
(i.e., £2-fold decreased expression) were chosen to identify
genes with significantly altered expression. Functional
category gene lists were created using KEGG (Kyoto En-
cyclopedia of Genes and Genomes) (69). Where available,
regulatory proteins for each gene were identified using
EcoCyc (https://ecocyc.org). Modeling of TF activities us-
ing TFInfer (2, 23, 58) and measuring similarity in TF ac-
tivities between two different conditions were performed as
described in (38).
Metal analyses
Culture samples (20ml) were taken before and after ad-
dition of 67 lM or 500lM CORM-401 and assayed for metal
content as before (38). Intracellular metal concentrations
were calculated using literature values for cell volume (23).
In control experiments, cultures were treated instead with
500lM MnSO4 –67 lM DTC or a saturated solution of CO
giving a final concentration of 500lM CO. To estimate total
numbers of manganese atoms per cell, the data of Outten and
O’Halloran (49) were used.
ANTIBACTERIAL ACTIVITIES OF A MANGANESE CORM 19
OM permeabilization assays
Outer membrane (OM) permeability of CORM-401 was
assayed using 1-N-phenylnaphthylamine (NPN) (61) at a fi-
nal concentration of 1 lM. Cells were grown to the expo-
nential phase (OD600 of 0.6), pelleted, then washed, and
resuspended in PBS. The final cell suspension was adjusted to
an OD600 of *0.5. Fluorescence was measured (kex= 340
nm, kem = 420 nm) using a Hitachi F-2500 fluorescence
spectrophotometer.
Spheroplasts and osmotic swelling measurements
To measure transmembrane ion fluxes, osmotic swelling
was measured by following changes in turbidity at 500 nm
following dilution of spheroplasts in isoosmotic (0.25M) salt
solutions as before except that EDTA/lysozyme treatment
was at 37C (74).
Western blotting for Spy and CpxP detection
This was done as before (74). In brief, CORM-401 or DTC/
MnSO4 was added to cultures to a final concentration of
67 lM and incubated for 2 h. For Spy quantitation, peri-
plasmic fractions were isolated using the Tris/sucrose/EDTA
(TSE) method (53). For CpxP, soluble fractions were made
after cell breakage by sonication, differential centrifugation,
followed by reduction with 200mM dithiothreitol, and sep-
aration by SDS-PAGE. Proteins were blotted using primary
rabbit anti-Spy/CpxP antibodies at 1:25,000/1:50,000 dilu-
tions, respectively. Anti-rabbit secondary antibodies were
incubated at a concentration of 1:50,000 before detection
using the ECL-Plus Western system (Amersham).
Growth and viability studies of CORM-401
in conjunction with antibiotics
Bacteria were grown in Evans medium with 20mM glu-
cose as a carbon source until 0.3 OD600 was reached; CORM-
401 (100lM) and/or trimethoprim (1.0 lg/ml) or cefotaxime
(1.0 lg/ml) were added alone or in combination. The inter-
actions of CORM-401 with antibiotics were determined us-
ing a broth microdilution checkerboard assay (44). Briefly,
bacteria were diluted in Evans medium to reach an OD of
around 0.3 (*5· 105 cfu/ml) and 200ll of the suspension
pipetted into each well of a 96-well plate. The concentrations
used for wild-typeMG1655 were CORM-401 (100–600 lM),
trimethoprim (1–16 lg/ml), and cefotaxime (1.0–32lg/ml).
For strain EC958, concentrations were CORM-401 (37.5–
600 lM), colistin (0.25–8lg/ml), doxycycline (6–96 lg/ml),
and gentamicin (0.125–4 lg/ml) added alone or in combi-
nation with CORM-401. Cultures were incubated at 37C
with shaking for 24 h using a Tecan Sunrise plate reader. The
concentrations tested were up to four 2-fold dilutions lower
than the minimal inhibitory concentration (MIC) and, where
possible, two 2-fold dilutions higher than the MIC. The MIC
was considered as the lowest concentration of the agent alone
or combined with CORM-401 that inhibited growth. Frac-
tional inhibitory concentration index (FICI) (44) was calcu-
lated to determine drug interaction and interpreted as follows:
FICI of two-drug combination = FICA + FICB, where FICA
is the MIC of drug A in combination with CORM-401/MIC
of drug A alone and FICB is the MIC of drug B in com-
bination with CORM-401/MIC of drug B alone. The results
indicate synergy when the calculated FICI £0.5, no inter-
action when FICI >0.5–4, and antagonism when the FICI
>4 (48).
Statistical analysis
All data are expressed as the mean – SEM, unless other-
wise stated. The comparison of the means was performed
using Student’s t-test for two groups of data. For comparison
of data across more than two groups, ANOVA, followed
by Bonferroni’s multiple comparison tests, was used. When
p < 0.05, data were considered significantly different.
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Abbreviations Used
CCCP¼ carbonylcyanide m-chlorophenylhydrazone
CORM¼ carbon monoxide-releasing molecule
DTC¼ dithiocarbamate, Na[S2CN(CH3)CH2COONa]
FIC¼ fractional inhibitory concentration
FICI¼ fractional inhibitory concentration index
ICP-MS¼ inductively coupled plasma mass spectrometry
MIC¼minimal inhibitory concentration
NPN¼N-phenyl-1-napthylamine
OM¼ outer membrane
PBS¼ phosphate-buffered saline
PTS¼ phosphotransferase system
TF¼ transcription factor
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